In this paper, the concepts of surrogate outcomes and intermediary outcomes, their correlation with the primary outcome, how to select surrogate outcomes and intermediary outcomes and the particular requirements for using surrogate outcomes in assessing TCM clinical efficacy were discussed and described.
论述了替代指标、中间指标的概念,其与主要结局指标之间的关系以及替代指标在临床疗效评价研究中的应用条件,同时讨论了在中医药疗效评价研究中如何选择替代指标和中间指标的问题。
